Sweden-bound: a Blue Gene node.
The machine, to be installed in the Parallel Computer Centre at the Royal Institute of Technology, will be used in combination with a high resolution PET scanner, in a SKr 20 million joint programme
“The combination of such enormous computer capacity and a high-resolution PET camera is unique,” said Hans Forssberg, Vice President of Karolinska Institutet. “Add to this the proximity to patients and clinical practice and we get entirely new opportunities for brain research from both a Swedish and international perspective.”
The SBI was set up by Karolinska Institutet, the Royal Institute of Technology and Stockholm University to carry out research into cognitive functions, such as memory and learning, emotions, action and perception. The institute is developing collaborations with industry to commercialise projects in advanced computer technology, memory research, medical image processing, and the rehabilitation of people with brain injuries.
“Blue Gene will give scientists extreme computational power to help them develop a deeper understanding of brain function so that they can improve the diagnosis and treatment of diseases of the nerve system and the brain,” says Ajay Royyuru, head of the Computational Biology Centre at IBM Research.
Royyuru announced that IBM is appointing two new researchers, one at IBM’s New York research labs and one at SBI, to develop new algorithms and methods for applying Blue Gene’s capacity in neuroscience.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
